Your browser doesn't support javascript.
RNA-based therapeutics: an overview and prospectus.
Zhu, Yiran; Zhu, Liyuan; Wang, Xian; Jin, Hongchuan.
  • Zhu Y; Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Zhu L; Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Wang X; Department of Medical Oncology, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
  • Jin H; Laboratory of Cancer Biology, Key Lab of Biotherapy in Zhejiang Province, Cancer Center of Zhejiang University, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China. jinhc@zju.edu.cn.
Cell Death Dis ; 13(7): 644, 2022 Jul 23.
Article in English | MEDLINE | ID: covidwho-1955799
ABSTRACT
The growing understanding of RNA functions and their crucial roles in diseases promotes the application of various RNAs to selectively function on hitherto "undruggable" proteins, transcripts and genes, thus potentially broadening the therapeutic targets. Several RNA-based medications have been approved for clinical use, while others are still under investigation or preclinical trials. Various techniques have been explored to promote RNA intracellular trafficking and metabolic stability, despite significant challenges in developing RNA-based therapeutics. In this review, the mechanisms of action, challenges, solutions, and clinical application of RNA-based therapeutics have been comprehensively summarized.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Small Interfering Type of study: Prognostic study Language: English Journal: Cell Death Dis Year: 2022 Document Type: Article Affiliation country: S41419-022-05075-2

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Small Interfering Type of study: Prognostic study Language: English Journal: Cell Death Dis Year: 2022 Document Type: Article Affiliation country: S41419-022-05075-2